WHERE NEXT FOR PRECISION MEDICINE FOR PROSTATE CANCER?

被引:0
|
作者
Efstathiou, E. [1 ]
机构
[1] Univ Athens, Dept Clin Therapeut, Athens, Greece
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
41IN
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Precision medicine for prostate cancer: An international perspective
    Hamid, Anis A.
    Sweeney, Christopher J.
    Hovens, Christopher
    Corcoran, Niall
    Azad, Arun A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 (12) : 392 - 401
  • [22] Precision oncology: where next?
    Gore, Martin
    Larkin, James
    LANCET ONCOLOGY, 2015, 16 (16): : 1593 - 1595
  • [23] Clinical Next Generation Sequencing for Precision Medicine in Cancer
    Dong, Ling
    Wang, Wanheng
    Li, Alvin
    Kansal, Rina
    Chen, Yuhan
    Chen, Hong
    Li, Xinmin
    CURRENT GENOMICS, 2015, 16 (04) : 253 - 263
  • [24] Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine
    Paolillo, Carmela
    Londin, Eric
    Fortina, Paolo
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2016, 76 : S84 - S91
  • [25] Targeting HER2 in prostate cancer: Where to next?
    Solit, David B.
    Rosen, Neal
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (03) : 241 - 243
  • [26] Impact of Phosphoproteomics in the Era of Precision Medicine for Prostate Cancer
    Ramroop, Johnny R.
    Stein, Mark N.
    Drake, Justin M.
    FRONTIERS IN ONCOLOGY, 2018, 8
  • [27] Immunotherapy as a Precision Medicine Tool for the Treatment of Prostate Cancer
    Adamaki, Maria
    Zoumpourlis, Vassilios
    CANCERS, 2021, 13 (02) : 1 - 23
  • [28] Precision Medicine Approaches to the Diagnosis and Management of Prostate Cancer
    Klein, Eric A.
    ONCOLOGY-NEW YORK, 2014, 28 (02): : 143 - +
  • [29] Advancing Precision Medicine for Prostate Cancer Through Genomics
    Roychowdhury, Sameek
    Chinnaiyan, Arul M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15) : 1866 - 1873
  • [30] Androgen receptor mutations for precision medicine in prostate cancer
    Shiota, Masaki
    Akamatsu, Shusuke
    Tsukahara, Shigehiro
    Nagakawa, Shohei
    Matsumoto, Takashi
    Eto, Masatoshi
    ENDOCRINE-RELATED CANCER, 2022, 29 (10) : R143 - R155